臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hung j s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 109 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-12T02:50:36Z	Ramucirumab plus triplet chemotherapy as an alternative salvage treatment for patients with metastatic colorectal cancer	Liang Y.-H.; Liang J.-T.; Lin B.-R.; Huang J.; Hung J.-S.; Lai S.-L.; Chen T.-C.; Tsai J.-H.; Cheng Y.-M.; Tsao T.-H.; Hsu W.-L.; Chen K.-H.; KUN-HUEI YEH
臺大學術典藏	2022-03-10T07:58:45Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-10T07:58:43Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-10T07:58:41Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; LI-HUI TSENG; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2022-03-10T07:58:38Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; LI-HUI TSENG; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2022-03-04T03:48:21Z	The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK	Huang J.; Che M.-I.; Lin N.-Y.; Hung J.-S.; Huang Y.-T.; WEI-CHOU LIN; Huang H.-C.; Lee P.-H.; Liang J.-T.; Huang M.-C.
臺大學術典藏	2022-01-25T02:56:51Z	Multielectrode radiofrequency ablation for resectable metachronous liver metastasis from colorectal cancer	Cheng H.-Y.; Huang K.-W.; Liang J.-T.; Lin B.-R.; Huang J.; Hung J.-S.; CHI-LING CHEN
臺大學術典藏	2021-09-15T01:20:59Z	Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling	Huang M.-J.; Hu R.-H.; Chou C.-H.; CHIA-LANG HSU; Liu Y.-W.; Huang J.; Hung J.-S.; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M.; Huang M.-C.
臺大學術典藏	2021-09-15T01:20:48Z	C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer	Lee P.-C.; Chen S.-T.; Kuo T.-C.; Lin T.-C.; Lin M.-C.; Huang J.; Hung J.-S.; CHIA-LANG HSU; Juan H.-F.; Lee P.-H.; Huang M.-C.
臺大學術典藏	2021-09-01T01:53:54Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:42:23Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-31T06:29:50Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏	2021-08-31T06:29:44Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-08-20T02:45:42Z	BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer	KUO-HSING CHEN; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2021-05-27T08:20:55Z	Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer	Li Y.-I.; Hung J.-S.; Yu T.-Y.; JYH-MING LIOU; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S.; Su C.-Y.; Li H.-Y.; Liang J.-T.
臺大學術典藏	2021-05-07T02:46:38Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; YI-HSIN LIANG; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2021-05-07T02:46:37Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	YI-HSIN LIANG; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏	2021-05-03T02:21:01Z	Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer	Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2021-05-03T02:21:00Z	The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK	Huang J.; Che M.-I.; Lin N.-Y.; Hung J.-S.; Huang Y.-T.; Lin W.-C.; Huang H.-C.; Lee P.-H.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏	2021-05-03T02:20:59Z	β1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells	Che M.-I.; Huang J.; Hung J.-S.; Lin Y.-C.; Huang M.-J.; Lai H.-S.; Hsu W.-M.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏	2021-05-03T02:20:58Z	C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying o-glycosylation of FGFR2	Hung J.-S.; Huang J.; Lin Y.-C.; Huang M.-J.; Lee P.-H.; Lai H.-S.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏	2021-05-03T02:20:57Z	Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients	Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏	2021-05-03T02:20:57Z	Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer	Li Y.-I.; Hung J.-S.; Yu T.-Y.; Liou J.-M.; Wei J.-N.; Kao H.-L.; Chuang L.-M.; Shun C.-T.; Lee P.-H.; Lai H.-S.; Su C.-Y.; Li H.-Y.; JIN-TUNG LIANG
臺大學術典藏	2021-05-03T02:20:56Z	β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer	Chen C.-H.; Wang S.-H.; Liu C.-H.; Wu Y.-L.; Wang W.-J.; Huang J.; Hung J.-S.; Lai I.-R.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏	2021-05-03T02:20:55Z	Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations	Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Jin-Tung Liang;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; JIN-TUNG LIANG; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.

Showing items 1-25 of 109 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2826152
	???header.visitor??? : 31798475 ???header.onlineuser??? : 901 ???header.sponsordeclaration???